INMD (inmodemd.com) צמיחת רווח נקי למניה השנה

InMode Ltd. develops radiofrequency systems for gynecology and aesthetics, minimizing regulatory risks in the US. Annual earnings per share growth demonstrates yield dynamics, where the current level is -19.20. Revenues are based on the sale of innovative devices for lifting and body contouring. Production efficiency is increasing through the implementation of automated robotic assembly and quality control lines.

For InMode Ltd., a leader in the minimally invasive RF technology segment for the B2B medtech market, the annual growth in net income per share serves as an indicator of the company's efficiency in monetizing innovation. This metric is calculated as the percentage deviation of the current EPS from the previous year's value, allowing investors to assess the momentum of fundamental recovery and the pace of business turnaround without the risk of overpaying for unconfirmed growth.